Various synthetic bone graft substitutes, demineralized bone matrix (DBM), bone morphogenetic proteins (BMPs), allogeneic bone cells, and mesenchymal stem cells (MSCs) currently are legally marketed bone graft substitutes; however, each of these products has a distinct regulator…